Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-20

Clinical Trial Update: Pediatric Risk of Hypothyroidism With Iodinated Contrast Media [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on pediatric risk of hypothyroidism with iodinated contrast media; study withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GE Healthcare | Conditions: Hypothyroidism | Phase 4 | Status: WITHDRAWN